Vanguard Group’s Rocket Pharmaceuticals RCKT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $15M | Sell |
6,122,461
-495,323
| -7% | -$1.21M | ﹤0.01% | 2699 |
|
|
2025
Q1 | $44.1M | Buy |
6,617,784
+40,189
| +0.6% | +$268K | ﹤0.01% | 2142 |
|
|
2024
Q4 | $82.7M | Buy |
6,577,595
+1,040,655
| +19% | +$13.1M | ﹤0.01% | 1947 |
|
|
2024
Q3 | $102M | Sell |
5,536,940
-271,610
| -5% | -$5.02M | ﹤0.01% | 1861 |
|
|
2024
Q2 | $125M | Buy |
5,808,550
+437,665
| +8% | +$9.42M | ﹤0.01% | 1733 |
|
|
2024
Q1 | $145M | Sell |
5,370,885
-76,680
| -1% | -$2.07M | ﹤0.01% | 1679 |
|
|
2023
Q4 | $163M | Buy |
5,447,565
+843,552
| +18% | +$25.3M | ﹤0.01% | 1617 |
|
|
2023
Q3 | $94.3M | Buy |
4,604,013
+4,085
| +0.1% | +$83.7K | ﹤0.01% | 1837 |
|
|
2023
Q2 | $91.4M | Buy |
4,599,928
+67,504
| +1% | +$1.34M | ﹤0.01% | 1900 |
|
|
2023
Q1 | $77.6M | Buy |
4,532,424
+345,882
| +8% | +$5.92M | ﹤0.01% | 1948 |
|
|
2022
Q4 | $81.9M | Buy |
4,186,542
+769,031
| +23% | +$15M | ﹤0.01% | 1914 |
|
|
2022
Q3 | $54.5M | Buy |
3,417,511
+62,020
| +2% | +$990K | ﹤0.01% | 2139 |
|
|
2022
Q2 | $46.2M | Buy |
3,355,491
+6,331
| +0.2% | +$87.1K | ﹤0.01% | 2231 |
|
|
2022
Q1 | $53.1M | Buy |
3,349,160
+48,022
| +1% | +$762K | ﹤0.01% | 2272 |
|
|
2021
Q4 | $72.1M | Buy |
3,301,138
+55,750
| +2% | +$1.22M | ﹤0.01% | 2151 |
|
|
2021
Q3 | $97M | Buy |
3,245,388
+37,623
| +1% | +$1.12M | ﹤0.01% | 2000 |
|
|
2021
Q2 | $142M | Buy |
3,207,765
+296,191
| +10% | +$13.1M | ﹤0.01% | 1814 |
|
|
2021
Q1 | $129M | Buy |
2,911,574
+874,115
| +43% | +$38.8M | ﹤0.01% | 1816 |
|
|
2020
Q4 | $112M | Buy |
2,037,459
+119,454
| +6% | +$6.55M | ﹤0.01% | 1775 |
|
|
2020
Q3 | $43.8M | Sell |
1,918,005
-10,279
| -0.5% | -$235K | ﹤0.01% | 2081 |
|
|
2020
Q2 | $40.4M | Buy |
1,928,284
+71,177
| +4% | +$1.49M | ﹤0.01% | 2108 |
|
|
2020
Q1 | $25.9M | Buy |
1,857,107
+59,707
| +3% | +$833K | ﹤0.01% | 2180 |
|
|
2019
Q4 | $40.9M | Buy |
1,797,400
+248,613
| +16% | +$5.66M | ﹤0.01% | 2209 |
|
|
2019
Q3 | $18M | Buy |
1,548,787
+46,438
| +3% | +$541K | ﹤0.01% | 2537 |
|
|
2019
Q2 | $22.5M | Buy |
1,502,349
+235,411
| +19% | +$3.53M | ﹤0.01% | 2451 |
|
|
2019
Q1 | $22.2M | Buy |
1,266,938
+129,868
| +11% | +$2.28M | ﹤0.01% | 2454 |
|
|
2018
Q4 | $16.9M | Buy |
1,137,070
+175,606
| +18% | +$2.6M | ﹤0.01% | 2519 |
|
|
2018
Q3 | $23.7M | Buy |
961,464
+112,180
| +13% | +$2.76M | ﹤0.01% | 2504 |
|
|
2018
Q2 | $16.7M | Buy |
849,284
+175,265
| +26% | +$3.44M | ﹤0.01% | 2645 |
|
|
2018
Q1 | $12.6M | Buy |
674,019
+428,963
| +175% | +$8.04M | ﹤0.01% | 2706 |
|
|
2017
Q4 | $2.56M | Buy |
245,056
+90,418
| +58% | +$944K | ﹤0.01% | 3350 |
|
|
2017
Q3 | $1.1M | Buy |
154,638
+75,460
| +95% | +$537K | ﹤0.01% | 3564 |
|
|
2017
Q2 | $602K | Sell |
79,178
-96,236
| -55% | -$732K | ﹤0.01% | 3692 |
|
|
2017
Q1 | $1.4M | Buy |
175,414
+72,608
| +71% | +$581K | ﹤0.01% | 3493 |
|
|
2016
Q4 | $2.51M | Sell |
102,806
-51,358
| -33% | -$1.25M | ﹤0.01% | 3287 |
|
|
2016
Q3 | $5.85M | Buy |
154,164
+5,396
| +4% | +$205K | ﹤0.01% | 2927 |
|
|
2016
Q2 | $4.43M | Buy |
148,768
+16,889
| +13% | +$503K | ﹤0.01% | 3047 |
|
|
2016
Q1 | $3.9M | Buy |
131,879
+15,695
| +14% | +$464K | ﹤0.01% | 3094 |
|
|
2015
Q4 | $5.27M | Buy |
116,184
+14,094
| +14% | +$639K | ﹤0.01% | 2967 |
|
|
2015
Q3 | $3.84M | Buy |
102,090
+93,665
| +1,112% | +$3.52M | ﹤0.01% | 3088 |
|
|
2015
Q2 | $165K | Buy |
+8,425
| New | +$165K | ﹤0.01% | 4068 |
|